These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 21457159)

  • 1. Overexpression of α-methylacyl-CoA racemase is associated with CTNNB1 mutations in hepatocellular carcinomas.
    Sekine S; Ogawa R; Ojima H; Kanai Y
    Histopathology; 2011 Apr; 58(5):712-9. PubMed ID: 21457159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of alpha methylacyl-coenzyme A racemase in differentiating hepatocellular carcinoma from dysplastic and nondysplastic liver cell lesions.
    Helal Tel A; Radwan NA; Abdel Kader Z; Helmy NA; Hammad SY
    Ann Diagn Pathol; 2012 Oct; 16(5):330-4. PubMed ID: 22542076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of alpha-methylacyl-CoA racemase by miR-138 via up-regulation of β-catenin in prostate cancer cells.
    Erdmann K; Kaulke K; Rieger C; Wirth MP; Fuessel S
    J Cancer Res Clin Oncol; 2017 Nov; 143(11):2201-2210. PubMed ID: 28741117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of overexpression of alpha methylacyl-coenzyme A racemase in hepatocellular carcinoma.
    Li W; Cagle PT; Botero RC; Liang JJ; Zhang Z; Tan D
    J Exp Clin Cancer Res; 2008 May; 27(1):2. PubMed ID: 18577240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. α-Methylacyl-CoA racemase (P504S) is a useful marker for the differential diagnosis of solid pseudopapillary neoplasm of the pancreas.
    Shen Y; Wang Z; Zhu J; Chen Y; Gu W; Liu Q
    Ann Diagn Pathol; 2014 Jun; 18(3):146-50. PubMed ID: 24675392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AMACR is highly expressed in gastric adenomas and intestinal-type carcinomas.
    Cho EY; Kim KM; Park CK; Kim JJ; Sohn TS; Kim DW
    APMIS; 2007 Jun; 115(6):713-8. PubMed ID: 17550379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AMACR is not applicable as a diagnostic tool in hepatocellular carcinoma.
    Willemoe GL; Vainer B
    APMIS; 2010 Feb; 118(2):85-90. PubMed ID: 20132171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-methylacyl-CoA racemase (AMACR/P504S) can distinguish hepatocellular carcinoma and dysplastic hepatocytes from benign nondysplastic hepatocytes.
    Guzman G; Wu SJ; Kajdacsy-Balla A; Cotler SJ
    Appl Immunohistochem Mol Morphol; 2006 Dec; 14(4):411-6. PubMed ID: 17122637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-methylacyl coenzyme A racemase overexpression in gallbladder carcinoma confers an independent prognostic indicator.
    Wu LC; Chen LT; Tsai YJ; Lin CM; Lin CY; Tian YF; Sheu MJ; Uen YH; Shiue YL; Wang YH; Yang SJ; Wu WR; Li SH; Iwamuro M; Kobayasshi N; Huang HY; Li CF
    J Clin Pathol; 2012 Apr; 65(4):309-14. PubMed ID: 22267983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of alpha-methylacyl-coenzyme A racemase in colorectal carcinoma bears clinical and pathologic significance.
    Lin A; Weiser MR; Klimstra DS; Paty PB; Tang LH; Al-Ahmadie H; Hoo Park S; Guillem JG; Temple L; Wong WD; Gerald WL; Shia J
    Hum Pathol; 2007 Jun; 38(6):850-6. PubMed ID: 17442371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-methylacyl-CoA racemase protein expression is associated with the degree of differentiation in breast cancer using quantitative image analysis.
    Witkiewicz AK; Varambally S; Shen R; Mehra R; Sabel MS; Ghosh D; Chinnaiyan AM; Rubin MA; Kleer CG
    Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1418-23. PubMed ID: 15941950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-methylacyl-CoA racemase (AMACR) in fine-needle aspiration specimens of prostate lesions.
    Kaić G; Tomasović-Loncarić C
    Diagn Cytopathol; 2009 Nov; 37(11):803-8. PubMed ID: 19459159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-methylacyl-CoA racemase (P504S)/34betaE12/p63 triple cocktail stain in prostatic adenocarcinoma after hormonal therapy.
    Sung MT; Jiang Z; Montironi R; MacLennan GT; Mazzucchelli R; Cheng L
    Hum Pathol; 2007 Feb; 38(2):332-41. PubMed ID: 17134736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A nonclassic CCAAT enhancer element binding protein binding site contributes to alpha-methylacyl-CoA racemase expression in prostate cancer.
    Zha S; Isaacs WB
    Mol Cancer Res; 2005 Feb; 3(2):110-8. PubMed ID: 15755877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-methylacyl-CoA racemase (AMACR) expression in normal prostatic glands and high-grade prostatic intraepithelial neoplasia (HGPIN): association with diagnosis of prostate cancer.
    Ananthanarayanan V; Deaton RJ; Yang XJ; Pins MR; Gann PH
    Prostate; 2005 Jun; 63(4):341-6. PubMed ID: 15602744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of pituitary tumor-transforming gene-1 in hepatocellular carcinoma.
    Su MC; Hsu HC; Liu YJ; Jeng YM
    Hepatogastroenterology; 2006; 53(68):262-5. PubMed ID: 16608036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-methylacyl-CoA-racemase expression in adenocarcinoma, dysplasia and non-neoplastic epithelium of the stomach.
    Lee WA
    Oncology; 2006; 71(3-4):246-50. PubMed ID: 17652945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-methylacyl-CoA racemase (P504S) expression in evolving carcinomas within benign prostatic hyperplasia and in cancers of the transition zone.
    Leav I; McNeal JE; Ho SM; Jiang Z
    Hum Pathol; 2003 Mar; 34(3):228-33. PubMed ID: 12673556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic alterations of Wnt signaling pathway-associated genes in hepatocellular carcinoma.
    Kim YD; Park CH; Kim HS; Choi SK; Rew JS; Kim DY; Koh YS; Jeung KW; Lee KH; Lee JS; Juhng SW; Lee JH
    J Gastroenterol Hepatol; 2008 Jan; 23(1):110-8. PubMed ID: 18171349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic and prognostic impact of beta-catenin alterations in pediatric liver tumors.
    Yamaoka H; Ohtsu K; Sueda T; Yokoyama T; Hiyama E
    Oncol Rep; 2006 Mar; 15(3):551-6. PubMed ID: 16465411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.